Biotechnology Stocks I Performance Guide: Immunovant, Inc. (IMVT)
IMVT has no dividends
Table and Chart of IMVT Performance
See what a $1,000 investment in IMVT is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| IMVT Returns | |
|---|---|
| Start Date | Jan-31-2020 |
| Start Price | $15.79 |
| End Date | Dec-01-2023 |
| End Price | $40.55 |
| # Prices | 48 |
| Min Date | Jun-30-2022 |
| Min Price | $3.90 |
| Max Date | Nov-30-2020 |
| Max Price | $49.19 |
| Total Return | 156.81% |
| Annualized Return | 26.59% |
| Current Value of $1,000 Purchase | $2,568 |
| Number Returns | 1,128 |
| Average Return | 50.17% |
| Number Profitable Returns | 538 |
| Percent Profitable Returns | 47.70% |
| Number Unprofitable Returns | 590 |
| Percent Unprofitable Returns | 52.30% |
| Profitable to Unprofitable Returns Ratio | 0.91 |
| IMVT Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $5,866,044,000 | Price to Sales |
| Earnings per Share | $-1.9600 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 23.3 |
| PRICE DATA | |
| 52 Week High | $44.19 |
| 52 Week Low | $14.05 |
| Analyst Target Price | $49.42 |
| 50-Day Moving Average | $34.67 |
| 200-Day Moving Average | $23.13 |
| FINANCIAL DATA | |
| Revenue per Share | $0 |
| Revenue | $0 |
| Profit Margin | 0% |
| Return on Equity | -0.788% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
IMVT Compare Returns with S&P 500
IMVT Trendline Chart